DiaMedica Therapeutics (DMAC) Receivables (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Receivables of $586000.0 for Q1 2026, up 21.58% year-over-year from $482000.0 in Q1 2025, and up 15.35% quarter-over-quarter from $508000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Receivables (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Receivables history runs 10 years deep, the most recent figure standing at $586000.0 for Q1 2026.
- In Q1 2026, Receivables rose 21.58% year-over-year to $586000.0; the TTM figure through Mar 2026 stood at $586000.0 (up 21.58% YoY), while the FY2025 annual figure was $508000.0, up 114.35% from the prior year.
- Receivables for Q1 2026 stood at $586000.0, up from $508000.0 in the prior quarter.
- The five-year high for Receivables was $790000.0 in Q1 2024, with the low at $75000.0 in Q3 2022.
- The 5-year median for Receivables is $440000.0 (2023), against an average of $394823.5.
- The sharpest annual moves came in 2022 and 2023: Receivables tumbled 72.84% in 2022, then surged 725.33% in 2023.
- DiaMedica Therapeutics' Receivables stood at $84000.0 in 2022, then surged by 423.81% to $440000.0 in 2023, then tumbled by 46.14% to $237000.0 in 2024, then soared by 114.35% to $508000.0 in 2025, then rose by 15.35% to $586000.0 in 2026.
- Business Quant data shows DMAC's Receivables at $586000.0 in Q1 2026, $508000.0 in Q4 2025, and $488000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 480,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 480,000.00 |
| Mar 31, 2026 | 586,000.00 |
| Dec 31, 2025 | 508,000.00 |
| Sep 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 303,000.00 |
| Mar 31, 2025 | 482,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Mar 31, 2024 | 790,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 619,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Mar 31, 2023 | 112,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 170,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 206,000.00 |